Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Journal of the American College of Cardiology
|
September 1, 2022
Validated Model for Prediction of Adverse Cardiac Outcome in Patients With Fabry Disease
Christopher Orsborne, Joshua Bradley, Laura J Bonnett, et al.
Trials
|
June 2, 2019
A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice
Ravi Vijapurapu, Rebecca Kozor, Derralynn A Hughes, et al.
Heart (British Cardiac Society)
|
August 26, 2019
Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy
Ravi Vijapurapu, Tarekegn Geberhiwot, Ana Jovanovic, et al.
JACC. Case Reports
|
June 7, 2023
Inflammatory Fabry Cardiomyopathy Demonstrated Using Simultaneous [
Christopher Orsborne, Jose M Anton-Rodrigez, Neal Sherratt, et al.
Molecular Genetics & Genomic Medicine
|
April 13, 2018
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study
Dominique P Germain, Eva Brand, Alessandro Burlina, et al.
Molecular Genetics and Metabolism Reports
|
February 19, 2019
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts
Dominique P Germain, Perry M Elliott, Bruno Falissard, et al.
ESC Heart Failure
|
February 27, 2020
Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis
Christoph Wanner, Ulla Feldt-Rasmussen, Ana Jovanovic, et al.
Journal of Inherited Metabolic Disease
|
July 20, 2024
Renal and multisystem effectiveness of 3.9 years of migalastat in a global real-world cohort: Results from the followME Fabry Pathfinders registry
Derralynn A Hughes, Gere Sunder-Plassmann, Ana Jovanovic, et al.
Journal of Inherited Metabolic Disease
|
March 19, 2020
RBCK1-related disease: A rare multisystem disorder with polyglucosan storage, auto-inflammation, recurrent infections, skeletal, and cardiac myopathy-Four additional patients and a review of the current literature
Rahul Phadke, Carola Hedberg-Oldfors, Renata S Scalco, et al.
Orphanet Journal of Rare Diseases
|
April 29, 2018
Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial
Raphael Schiffmann, Daniel G Bichet, Ana Jovanovic, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Journal of the American College of Cardiology
|
September 1, 2022
Validated Model for Prediction of Adverse Cardiac Outcome in Patients With Fabry Disease
Christopher Orsborne, Joshua Bradley, Laura J Bonnett, et al.
Trials
|
June 2, 2019
A randomised controlled trial evaluating arrhythmia burden, risk of sudden cardiac death and stroke in patients with Fabry disease: the role of implantable loop recorders (RaILRoAD) compared with current standard practice
Ravi Vijapurapu, Rebecca Kozor, Derralynn A Hughes, et al.
Heart (British Cardiac Society)
|
August 26, 2019
Study of indications for cardiac device implantation and utilisation in Fabry cardiomyopathy
Ravi Vijapurapu, Tarekegn Geberhiwot, Ana Jovanovic, et al.
JACC. Case Reports
|
June 7, 2023
Inflammatory Fabry Cardiomyopathy Demonstrated Using Simultaneous [
Christopher Orsborne, Jose M Anton-Rodrigez, Neal Sherratt, et al.
Molecular Genetics & Genomic Medicine
|
April 13, 2018
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study
Dominique P Germain, Eva Brand, Alessandro Burlina, et al.
Molecular Genetics and Metabolism Reports
|
February 19, 2019
The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts
Dominique P Germain, Perry M Elliott, Bruno Falissard, et al.
ESC Heart Failure
|
February 27, 2020
Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis
Christoph Wanner, Ulla Feldt-Rasmussen, Ana Jovanovic, et al.
Journal of Inherited Metabolic Disease
|
July 20, 2024
Renal and multisystem effectiveness of 3.9 years of migalastat in a global real-world cohort: Results from the followME Fabry Pathfinders registry
Derralynn A Hughes, Gere Sunder-Plassmann, Ana Jovanovic, et al.
Journal of Inherited Metabolic Disease
|
March 19, 2020
RBCK1-related disease: A rare multisystem disorder with polyglucosan storage, auto-inflammation, recurrent infections, skeletal, and cardiac myopathy-Four additional patients and a review of the current literature
Rahul Phadke, Carola Hedberg-Oldfors, Renata S Scalco, et al.
Orphanet Journal of Rare Diseases
|
April 29, 2018
Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial
Raphael Schiffmann, Daniel G Bichet, Ana Jovanovic, et al.
Page
of 6